Astellas Strengthens Next-Gen I-O Hand With $665m Xyphos Buy

Japanese Major In Year-End Shopping Spree

 
• By Ian Haydock

Astellas pays to play in next-generation immuno-oncology through deal for young, privately held US venture and its novel modulation platform.

3d illustration of immune system T cells attacking cancer cells (CAR T-cell therapy) - Illustration
Astellas Looks To US Buy For Next-Generation CAR-Ts • Source: Shutterstock

More from Deals

More from Business